GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (FRA:IP4) » Definitions » Other Stockholders Equity

InnoCan Pharma (FRA:IP4) Other Stockholders Equity : €-0.00 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is InnoCan Pharma Other Stockholders Equity?

InnoCan Pharma's Other Stockholders Equity for the quarter that ended in Dec. 2024 was €-0.00 Mil.

InnoCan Pharma's quarterly Other Stockholders Equity increased from Jun. 2024 (€-0.00 Mil) to Sep. 2024 (€0.00 Mil) but then declined from Sep. 2024 (€0.00 Mil) to Dec. 2024 (€-0.00 Mil).

InnoCan Pharma's annual Other Stockholders Equity declined from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€-0.00 Mil) and declined from Dec. 2023 (€-0.00 Mil) to Dec. 2024 (€-0.00 Mil).


InnoCan Pharma Other Stockholders Equity Historical Data

The historical data trend for InnoCan Pharma's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Other Stockholders Equity Chart

InnoCan Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial - - - - -

InnoCan Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

InnoCan Pharma Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


InnoCan Pharma Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


InnoCan Pharma Business Description

Traded in Other Exchanges
Address
1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.

InnoCan Pharma Headlines

No Headlines